| HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 T Dragic, V Litwin, GP Allaway, SR Martin, Y Huang, KA Nagashima, ... Nature 381 (6584), 667-673, 1996 | 4383 | 1996 |
| Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7 P Wang, MS Nair, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu, B Zhang, ... Nature 593 (7857), 130-135, 2021 | 2322 | 2021 |
| The role of a mutant CCR5 allele in HIV–1 transmission and disease progression Y Huang, WA Paxton, SM Wolinsky, AU Neumann, L Zhang, T He, S Kang, ... Nature medicine 2 (11), 1240-1243, 1996 | 1790 | 1996 |
| Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike L Liu, P Wang, MS Nair, J Yu, M Rapp, Q Wang, Y Luo, JFW Chan, V Sahi, ... Nature 584 (7821), 450-456, 2020 | 1470 | 2020 |
| Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 L Liu, S Iketani, Y Guo, JFW Chan, M Wang, L Liu, Y Luo, H Chu, Y Huang, ... Nature 602 (7898), 676-681, 2022 | 1240 | 2022 |
| Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization P Wang, RG Casner, MS Nair, M Wang, J Yu, G Cerutti, L Liu, PD Kwong, ... Cell host & microbe 29 (5), 747-751. e4, 2021 | 966 | 2021 |
| Antibody evasion properties of SARS-CoV-2 Omicron sublineages S Iketani, L Liu, Y Guo, L Liu, JFW Chan, Y Huang, M Wang, Y Luo, J Yu, ... Nature 604 (7906), 553-556, 2022 | 805 | 2022 |
| Antibody evasion by SARS-CoV-2 Omicron subvariants BA. 2.12. 1, BA. 4 and BA. 5 Q Wang, Y Guo, S Iketani, MS Nair, Z Li, H Mohri, M Wang, J Yu, ... Nature 608 (7923), 603-608, 2022 | 700 | 2022 |
| A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids L Yang, Y Han, BE Nilsson-Payant, V Gupta, P Wang, X Duan, X Tang, ... Cell stem cell 27 (1), 125-136. e7, 2020 | 693 | 2020 |
| A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation LG Kostrikis, Y Huang, JP Moore, SM Wolinsky, L Zhang, Y Guo, ... Nature medicine 4 (3), 350-353, 1998 | 513 | 1998 |
| Identification of SARS-CoV-2 inhibitors using lung and colonic organoids Y Han, X Duan, L Yang, BE Nilsson-Payant, P Wang, F Duan, X Tang, ... Nature 589 (7841), 270-275, 2021 | 502 | 2021 |
| Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite G Cerutti, Y Guo, T Zhou, J Gorman, M Lee, M Rapp, ER Reddem, J Yu, ... Cell host & microbe 29 (5), 819-833. e7, 2021 | 494 | 2021 |
| Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4 … JP Moore, JA McKeating, YX Huang, A Ashkenazi, DD Ho Journal of virology 66 (1), 235-243, 1992 | 378 | 1992 |
| The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine C Trumpfheller, M Caskey, G Nchinda, MP Longhi, O Mizenina, Y Huang, ... Proceedings of the National Academy of Sciences 105 (7), 2574-2579, 2008 | 353 | 2008 |
| Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A J Idoyaga, A Lubkin, C Fiorese, MH Lahoud, I Caminschi, Y Huang, ... Proceedings of the National Academy of Sciences 108 (6), 2384-2389, 2011 | 333 | 2011 |
| HIV-1 subtype and second-receptor use L Zhang, Y Huang, T He, Y Cao, DD Ho Nature 383 (6603), 768-768, 1996 | 311 | 1996 |
| Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine C Trumpfheller, JS Finke, CB López, TM Moran, B Moltedo, H Soares, ... The Journal of experimental medicine 203 (3), 607-617, 2006 | 309 | 2006 |
| Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification V Simon, V Zennou, D Murray, Y Huang, DD Ho, PD Bieniasz PLoS pathogens 1 (1), e6, 2005 | 295 | 2005 |
| The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells G Nchinda, J Kuroiwa, M Oks, C Trumpfheller, CG Park, Y Huang, ... The Journal of clinical investigation 118 (4), 1427-1436, 2008 | 236 | 2008 |
| In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers S Vasan, A Hurley, SJ Schlesinger, D Hannaman, DF Gardiner, DP Dugin, ... PloS one 6 (5), e19252, 2011 | 227 | 2011 |
